InsidersTradesSigma
Clover Biopharmaceuticals, Ltd. - B Stock: price and insider trades · Hong Kong · HKEX
Track the Clover Biopharmaceuticals, Ltd. - B stock price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on HK HK, under the oversight of HKEX. Operating in the Health Care sector, Clover Biopharmaceuticals, Ltd. - B has recorded 30 reports. Market capitalisation: €1.9bn. The latest transaction was reported on 7 July 2026 (Sale). Among the most active insiders: Liang Peng. Every trade is openly available.
30
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
€466,954
9 ops.
Sell Volume
14Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations30 total
50,000 shares@ €0.1920.0038% mcap2.2% of flowShareXHKGHKEX:DA20260707E00164
50,000 shares@ €0.1932ShareXHKGHKEX:DA20260701E00013
100,000 shares@ €0.1836ShareXHKGHKEX:DA20260701E00012
14,500 sharesShareXHKGHKEX:DA20260617E00208
600,000 shares@ €0.34360.083% mcap48.0% of flowShareXHKGHKEX:DA20260424E00084
300,000 shares@ €0.33730.041% mcap23.6% of flowShareXHKGHKEX:DA20260417E00037
49,000 sharesShareXHKGHKEX:DA20260409E00113
49,000 sharesShareXHKGHKEX:DA20260409E00086
383,000 sharesShareXHKGHKEX:DA20260409E00099
Ideal exit: 28 Dec 2026 (T+270)
1,086,000 sharesShareXHKGHKEX:DA20260409E00098
1,326,875 sharesShareXHKGHKEX:DA20260409E00100
Ideal exit: 28 Dec 2026 (T+270)
189,500 sharesShareXHKGHKEX:DA20260409E00094
572,500 sharesShareXHKGHKEX:DA20260409E00092
49,000 sharesShareXHKGHKEX:DA20260409E00117
49,000 sharesShareXHKGHKEX:DA20260409E00126
2,412,875 sharesShareXHKGHKEX:DA20260409E00096
49,000 sharesShareXHKGHKEX:DA20260409E00105
49,000 sharesShareXHKGHKEX:DA20260409E00120
9,840 sharesShareXHKGHKEX:DA20260403E00017
Ideal exit: 26 Dec 2026 (T+270)
500 sharesShareXHKGHKEX:DA20260403E00016
10,340 sharesShareXHKGHKEX:DA20260403E00015
340,000 sharesShareXHKGHKEX:DA20260401E00056
Ideal exit: 22 Dec 2026 (T+270)
340,000 sharesShareXHKGHKEX:DA20260401E00045
Ideal exit: 22 Dec 2026 (T+270)
340,000 sharesShareXHKGHKEX:DA20260401E00054
Ideal exit: 22 Dec 2026 (T+270)
6,577,500 sharesShareXHKGHKEX:DA20260401E00050
Ideal exit: 22 Dec 2026 (T+270)
25 of 30 declarations
About Clover Biopharmaceuticals, Ltd. - B
Clover Biopharmaceuticals, Ltd. is a biopharmaceutical company focused on developing vaccines and therapies for infectious diseases. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.